Comparison of Intermediate Cervical Plexus Block and Superficial Cervical Plexus Block
Launched by KONYA MERAM STATE HOSPITAL · May 1, 2022
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
This prospective randomized study will be performed on patients undergoing central venous catheterization into the internal jugular vein. Patients who agreed to participate in the study will be divided into two groups using the closed-envelope randomization method; Group S: Superficial cervical plexus block group Group I: Intermediate cervical plexus group
After routine monitoring and RAMSEY 2 level sedation is achieved, a superficial or intermediate cervical plexus block will be applied according to randomization by a researcher experienced in a peripheral block. Patient pain level (to be...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult volunteer patients who require central catheterization into the internal jugular vein for any reason
- • Patients with mental and health status who can understand the research questions.
- • Patients who read the informed consent form and gave a signed declaration of acceptance
- Exclusion Criteria:
- • Patients with psychiatric disorders
- • Patients who are in poor general condition and require urgent intervention
- • Patients who cannot answer the survey questions
- • Patients followed as intubated
- • Patients with hypersensitivity to the local anesthetic agents to be used in the study or to the substances contained in it.
- • Patients with contraindications for cervical plexus block application
- • Patients who are unwilling to participate in the study for any reason
About Konya Meram State Hospital
Konya Meram State Hospital is a leading healthcare institution committed to advancing medical research and improving patient outcomes through clinical trials. Located in Konya, Turkey, the hospital is equipped with state-of-the-art facilities and a dedicated team of healthcare professionals who specialize in various medical fields. By participating in clinical trials, Konya Meram State Hospital aims to contribute to the development of innovative therapies and treatment protocols, ensuring that patients benefit from the latest advancements in medicine. The hospital prioritizes patient safety, ethical standards, and rigorous scientific methodologies, making it a trusted partner in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials